Omeprazole and Renal failure acute - a phase IV clinical study of FDA data

Summary:

Renal failure acute is found among people who take Omeprazole, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Omeprazole and have Renal failure acute. It is created by eHealthMe based on reports of 380,957 people who have side effects when taking Omeprazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 09, 2023

380,957 people reported to have side effects when taking Omeprazole.
Among them, 3,429 people (0.9%) have Renal failure acute.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 360,348 Omeprazole users for its effectiveness, alternative drugs and more.

What is Renal failure acute?

Renal failure acute (rapid kidney dysfunction) is found to be associated with 3,114 drugs and 3,096 conditions by eHealthMe.

Number of Omeprazole and Renal failure acute reports submitted per year:

Could Omeprazole cause Renal failure acute?

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and have Renal failure acute?

Check whether Renal failure acute is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .

Related studies

How severe was Renal failure acute and when was it recovered:

Renal failure acute in Omeprazole

Expand to all the drugs that have ingredients of omeprazole:

Renal failure acute and drugs with ingredients of omeprazole (4,572 reports)

Alternative drugs to, pros and cons of Omeprazole:

Omeprazole (360,348 reports)

Common Omeprazole side effects:

Fatigue (feeling of tiredness): 22,124 reports
Diarrhea: 20,827 reports
Chronic kidney disease: 19,690 reports
Breathing difficulty: 18,194 reports
Drug ineffective: 17,125 reports
Pain: 15,867 reports
Dizziness: 15,725 reports

Browse all side effects of Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Renal failure acute treatments and more:

Renal failure acute (73,864 reports)

COVID vaccines that are related to Renal failure acute:

Common drugs associated with Renal failure acute:

All the drugs that are associated with Renal failure acute:

Renal failure acute (3,114 drugs)

Common conditions associated with Renal failure acute:

High blood pressure: 6,913 reports
Type 2 diabetes: 3,046 reports
Diabetes: 2,594 reports
Pain: 2,373 reports
Atrial fibrillation/flutter: 2,264 reports
Multiple myeloma: 1,881 reports

All the conditions that are associated with Renal failure acute:

Renal failure acute (3,096 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.